Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05801614 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction

Study acronym: CarborCal
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Interventions: Low carbohydrate diet (Other) to Low carb diet (Other)
    • Study description shortened, about 682 words
    v4
  2. Minor Interventions: Low carbohydrate diet or low caloric diet (Other) to Low carbohydrate diet (Other)
    • Study description expanded, about 1,348 words
    v3
  3. Minor Interventions: Dietintervention (Other) to Low carbohydrate diet or low caloric diet (Other)
    • Study description shortened, about 1,423 words
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
5,087 trials monitored
See 222 trials at risk
3,874 trials monitored
See 152 trials at risk
2,231 trials monitored
See 111 trials at risk
This is a randomized controlled trial to determine whether a low-carbohydrate (LC) diet can lead to normalized blood glucose levels in patients with short duration of type 2 diabetes (T2D). Previous studies have shown that caloric restricted diet leading to weight loss can normalize blood glucose levels in approximately 50% of patients with a short duration of diabetes type 2. However, caloric restriction is difficult to maintain. Less restrictive approaches are needed. The hypothesis in this study is that Low carbohydrate diet can results in normalized blood glucose levels in T2D and can be an alternative to caloric restriction diet, both in the shorter term (3 months) and longer term (15 months). The outcome of this study leading to reduction of HbA1c is important for prevention of diabetes complications.
Trial Details
NCT Number NCT05801614
Lead Sponsor Region Stockholm
Conditions
(from sponsor)
Diabetes Mellitus Type 2 in Obese
Related terms Diabetes Mellitus, Type 2
Enrollment 286 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov